Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Updates in Oncology
15:43

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Adjuvant TKI Therapy in Early Stage and Metastatic GIST: Which Patients Need It?

FEATURING George Demetri
  • 1,246 views
  • June 6, 2019
  • 6
17:55

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Current State of Knowledge and Unmet Needs in EGFRvIII and CMV Antigenic Targeting Immunotherapy in Glioblastoma

FEATURING Amy Heimberger
  • 466 views
  • June 6, 2019
  • 5
07:25

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Managing Metastatic Non-GIST Soft Tissue Sarcomas: Combination Chemotherapy vs. Single Agent Doxorubicin

FEATURING George Demetri
  • 53 views
  • June 6, 2019
06:11

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Histology-Specific Management of Non-GIST Soft Tissue Sarcomas: Pazopanib, Trabectedin, and Eribulin

FEATURING George Demetri
  • 63 views
  • June 6, 2019
12:23

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Next Generation Sequencing and Molecular Targeted Therapies in Patients with Metastatic Undifferentiated Sarcomas

FEATURING George Demetri
  • 104 views
  • June 6, 2019
32:33

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAILORx and Prosigna Trials Affect Practice?

FEATURING Lisa Carey
  • 1,876 views
  • May 30, 2019
  • 9
11:57

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

HR+/HER2- Breast Cancer - Who Needs Extended Adjuvant Endocrine Therapy

FEATURING Lisa Carey
  • 719 views
  • May 30, 2019
  • 3
22:56

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Advanced Ovarian Cancer: Neoadjuvant Chemotherapy or Primary Surgery?

FEATURING Robert Coleman
  • 854 views
  • May 29, 2019
  • 4
08:13

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Biologics in First-Line Ovarian Cancer Treatment: AAi, anti-VEGF, PARPi, CPi

FEATURING Robert Coleman
  • 221 views
  • May 29, 2019
16:23

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Combination Therapeutic Strategies in Recurrent Ovarian Cancer: (Platinum-Based) Chemotherapy, IO and PARPi

FEATURING Robert Coleman
  • 1,205 views
  • May 29, 2019
  • 7
10:13

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Mechanisms of Immune Activation and Inhibition in Glioblastoma: CPi and Enrichment Biomarkers

FEATURING Amy Heimberger
  • 302 views
  • May 30, 2019
  • 3
11:41

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

STAT 3 Small Molecule Inhibitor WP1066 - Immune Suppressive Mechanism in Glioblastoma Patients?

FEATURING Amy Heimberger
  • 96 views
  • May 30, 2019
  • 1
10:23

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Overview of Systemic Treatments in Bladder Cancer in 2019

FEATURING Sandy Srinivas
  • 550 views
  • April 23, 2019
  • 1
15:46

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Neoadjuvant and Adjuvant Therapy in Localized Bladder Cancer: IO vs. Chemotherapy

FEATURING Sandy Srinivas
  • 799 views
  • April 23, 2019
  • 4
07:12

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

IO Therapy in Metastatic Urothelial Cancer (mUC)

FEATURING Sandy Srinivas
  • 471 views
  • April 23, 2019
  • 2
10:25

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Promising New Drugs in Advanced Urothelial Cancer: Antibody+CPi+PARPi

FEATURING Sandy Srinivas
  • 421 views
  • April 23, 2019
  • 1
05:17

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Is There a Role for Adjuvant Therapy in Localized Renal Cell Carcinoma? Ongoing Randomized Clinical Trials

FEATURING Jeffrey Graham
  • 547 views
  • April 24, 2019
  • 2
09:45

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Personalized Approach to Metastatic Renal Cell Carcinoma: Prognostic Factors and Models

FEATURING Jeffrey Graham
  • 434 views
  • April 24, 2019
  • 1
16:29

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Personalized Approach to Metastatic Renal Cell Carcinoma: First-Line Systemic Therapy

FEATURING Jeffrey Graham
  • 454 views
  • April 24, 2019
  • 2
10:04

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma and Beyond - the Role of Cytoreductive Nephrectomy and Biomarkers

FEATURING Jeffrey Graham
  • 370 views
  • April 24, 2019
49:30

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Optimizing Your Oncology Practice

FEATURING Elain Towle
  • 708 views
  • March 19, 2019
  • 5
46:03

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Integrating Integrative Medicine Into Supportive Care: Are We Ready?

FEATURING Gabriel Lopez
  • 25 views
  • March 19, 2019
44:31

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Drug Pricing and Oncology Practice

FEATURING Vinay Prasad
  • 203 views
  • March 19, 2019
  • 2